Moderna gets the ultimate Wall Street validation: It’s being added to the S&P 500
By Paul R. La Monica, CNN Business Moderna, the biotech that became a household name with its Covid-19 vaccine, is getting the ultimate Wall Street validation: It’s being added to the S&P 500 index. S&P made the announcement late Thursday, and shares of Moderna surged 10% Friday morning on the news. The stock is now
Continue Reading